Rui Kang
Impact in
- Cancer Research top 0.02%
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
- Pulmonary and Respiratory Medicine top 0.01%
- Ferroptosis and cancer prognosis
Papers in
-
- Advanced Glycation End Products research 60
-
- Ferroptosis and cancer prognosis 109
- Co-authors
- Daolin Tang (251 shared papers)Guido Kroemer (47 shared papers)Xin Chen (21 shared papers)Michael T. Lotze (45 shared papers)Herbert J. Zeh (58 shared papers)Daniel J. Klionsky (29 shared papers)Jiao Liu (30 shared papers)Yangchun Xie (30 shared papers)
- Journals
- Autophagy (29 papers)Biochemical and Biophysical Research Communications (23 papers)Frontiers in Cell and Developmental Biology (8 papers)Nature Communications (7 papers)Cancer Gene Therapy (7 papers)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Rui Kang
289 papers receiving 52.4k citations
Rui Kang's Hit Papers
Peers
Comparison fields: 5 of 182
- Cancer Research 15.7k
- Pulmonary and Respiratory Medicine 25.8k
- Clinical Biochemistry 4.0k
- Molecular Biology 26.0k
- Immunology 6.9k
Countries citing papers authored by Rui Kang
This map shows the geographic impact of Rui Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Kang more than expected).
Fields of papers citing papers by Rui Kang
This network shows the impact of papers produced by Rui Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Kang. The network helps show where Rui Kang may publish in the future.
Co-authors
The 25 scholars most cited alongside Rui Kang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 296 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ferroptosis: molecular mechanisms and health implications Hit paper breakdown → | 2020 | 3277 |
| 2 | Ferroptosis: process and function Hit paper breakdown → | 2016 | 3125 |
| 3 | Broadening horizons: the role of ferroptosis in cancer Hit paper breakdown → | 2021 | 2306 |
| 4 | The molecular machinery of regulated cell death Hit paper breakdown → | 2019 | 2064 |
| 5 | Autophagy promotes ferroptosis by degradation of ferritin Hit paper breakdown → | 2016 | 1940 |
| 6 | Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells Hit paper breakdown → | 2015 | 1705 |
| 7 | Ferroptosis: machinery and regulation Hit paper breakdown → | 2020 | 1687 |
| 8 | PAMP s and DAMP s: signal 0s that spur autophagy and immunity Hit paper breakdown → | 2012 | 1000 |
| 9 | Ferroptosis is a type of autophagy-dependent cell death Hit paper breakdown → | 2019 | 916 |
| 10 | HMGB1 in health and disease Hit paper breakdown → | 2014 | 825 |
| 11 | The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity Hit paper breakdown → | 2017 | 799 |
| 12 | Iron Metabolism in Ferroptosis Hit paper breakdown → | 2020 | 775 |
| 13 | Autophagy-Dependent Ferroptosis: Machinery and Regulation Hit paper breakdown → | 2020 | 688 |
| 14 | Ferroptosis in infection, inflammation, and immunity Hit paper breakdown → | 2021 | 649 |
| 15 | AMPK-Mediated BECN1 Phosphorylation Promotes Ferroptosis by Directly Blocking System Xc– Activity Hit paper breakdown → | 2018 | 638 |
| 16 | The mechanism of HMGB1 secretion and release Hit paper breakdown → | 2022 | 633 |
| 17 | Signaling pathways and defense mechanisms of ferroptosis Hit paper breakdown → | 2021 | 597 |
| 18 | Metallothionein‐1G facilitates sorafenib resistance through inhibition of ferroptosis Hit paper breakdown → | 2016 | 591 |
| 19 | The tumor suppressor protein p53 and the ferroptosis network Hit paper breakdown → | 2018 | 577 |
| 20 | HSPB1 as a novel regulator of ferroptotic cancer cell death Hit paper breakdown → | 2015 | 570 |
About Rui Kang
Rui Kang is a scholar working on Clinical Biochemistry, Pulmonary and Respiratory Medicine, Cancer Research, Immunology and Molecular Biology, having authored 296 papers that have together received 53.0k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (109 papers), Advanced Glycation End Products research (60 papers), RNA modifications and cancer (55 papers), Autophagy in Disease and Therapy (49 papers), Cancer, Lipids, and Metabolism (38 papers), Inflammasome and immune disorders (27 papers), Immune Response and Inflammation (22 papers) and Epigenetics and DNA Methylation (21 papers). The work is most often cited by research in Cancer Research (15.7k citations), Pulmonary and Respiratory Medicine (25.8k citations), Clinical Biochemistry (4.0k citations), Molecular Biology (26.0k citations) and Immunology (6.9k citations). Rui Kang has collaborated with scholars based in United States, China and France. Frequent co-authors include Daolin Tang, Guido Kroemer, Xin Chen, Michael T. Lotze, Herbert J. Zeh, Daniel J. Klionsky, Jiao Liu, Yangchun Xie, Xinxin Song and Xiaofang Sun. Their work appears in journals such as Autophagy, Biochemical and Biophysical Research Communications, Frontiers in Cell and Developmental Biology, Nature Communications and Cancer Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.